Evidence for a causal relationship between respiratory syncytial virus infection and asthma

Respiratory syncytial virus (RSV) infects all children early in life, is the most common cause of infant lower respiratory tract infections, and causes disease exacerbations in children with asthma. Episodes of lower respiratory tract infection in early life are associated with asthma development. Whether RSV infection early in life directly causes asthma or simply identifies infants who are genetically predisposed to develop subsequent wheezing is debatable. Recent studies suggest that these two explanations are not mutually exclusive, and are likely both important in asthma development. An open-label study of RSV immunoprophylaxis administered to preterm infants reduced recurrent wheezing by 50%. Clinical trials of infant RSV prevention, delay or severity reduction on the outcome of childhood asthma would confirm the causal relationship between RSV infection and asthma, and offer a primary prevention strategy.

[1]  D. Spandidos,et al.  T280M Variation of the CX3C Receptor Gene Is Associated With Increased Risk for Severe Respiratory Syncytial Virus Bronchiolitis , 2006, The Pediatric infectious disease journal.

[2]  Tebeb Gebretsadik,et al.  The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. , 2009, The Journal of allergy and clinical immunology.

[3]  T. Hudson,et al.  Association study between the CX3CR1 gene and asthma , 2006, Genes and Immunity.

[4]  D. Postma,et al.  Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. , 2002, American journal of human genetics.

[5]  Marilyn Halonen,et al.  Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study , 2008, The Lancet.

[6]  D. Kwiatkowski,et al.  Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. , 2005, The Journal of infectious diseases.

[7]  M. Rämet,et al.  Surfactant Protein D Gene Polymorphism Associated with Severe Respiratory Syncytial Virus Infection , 2002, Pediatric Research.

[8]  D. Kwiatkowski,et al.  Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  W. Busse,et al.  Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. , 1996, American journal of respiratory and critical care medicine.

[10]  P. Gustafsson,et al.  Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. , 2005, American journal of respiratory and critical care medicine.

[11]  B. Adkins,et al.  Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[12]  E. Gelfand,et al.  The Enhancement or Prevention of Airway Hyperresponsiveness during Reinfection with Respiratory Syncytial Virus Is Critically Dependent on the Age at First Infection and IL-13 Production1 , 2005, The Journal of Immunology.

[13]  L. Aloe,et al.  Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. , 2005, American journal of respiratory and critical care medicine.

[14]  A. Heinzmann,et al.  Interleukin (IL)-18 Polymorphism 133C/G Is Associated With Severe Respiratory Syncytial Virus Infection , 2007, The Pediatric infectious disease journal.

[15]  G L Hall,et al.  Altered respiratory tissue mechanics in asymptomatic wheezy infants. , 2001, American journal of respiratory and critical care medicine.

[16]  L. Parada,et al.  The molecular basis for understanding neurotrophins and their relevance to neurologic disease. , 2000, Archives of neurology.

[17]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[18]  T. Beaty,et al.  Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. , 2005, The Journal of allergy and clinical immunology.

[19]  Chengping Hu,et al.  Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[20]  C. Mandl,et al.  Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. , 1999, American journal of respiratory and critical care medicine.

[21]  S. Remes,et al.  Respiratory morbidity 20 years after RSV infection in infancy , 2004, Pediatric pulmonology.

[22]  D. Spandidos,et al.  RANTES Promoter Gene Polymorphisms and Susceptibility to Severe Respiratory Syncytial Virus-Induced Bronchiolitis , 2008, The Pediatric infectious disease journal.

[23]  R. Parker,et al.  Respiratory syncytial virus infection does not increase allergen‐induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice , 2001, Journal of medical virology.

[24]  H. Meissner,et al.  Respiratory syncytial virus infection and recurrent wheezing: a complex relationship. , 2007, The Journal of pediatrics.

[25]  E. Walsh,et al.  Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. , 1990, The Journal of infectious diseases.

[26]  J. Mills,et al.  Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. , 1999, The Journal of infectious diseases.

[27]  A. de Francisco,et al.  Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules. , 1998, Vaccine.

[28]  R. Garofalo,et al.  Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection , 2002, The Pediatric infectious disease journal.

[29]  D. Kwiatkowski,et al.  Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. , 2001, American journal of human genetics.

[30]  D. Nowak,et al.  Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. , 2005, The Journal of allergy and clinical immunology.

[31]  Patricia Kipnis,et al.  Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life. , 2010, Archives of pediatrics & adolescent medicine.

[32]  A. Sherriff,et al.  Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[33]  A. Heinzmann,et al.  Impact of IL8 and IL8-Receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections , 2006, Clinical and molecular allergy : CMA.

[34]  F. Martinez,et al.  Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. , 1998, The Journal of allergy and clinical immunology.

[35]  R. Holman,et al.  Bronchiolitis-associated hospitalizations among US children, 1980-1996. , 1999, JAMA.

[36]  C. Xavier,et al.  [Changes in placental morphology of small for gestational age newborns]. , 2002, Jornal de pediatria.

[37]  T. Miike,et al.  Increased secretion of IL‐18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis , 2001, Clinical and experimental immunology.

[38]  A. Heinzmann,et al.  Haplotypes of surfactant protein C are associated with common paediatric lung diseases , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[39]  Belinda Wang,et al.  The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice , 2008, Journal of Virology.

[40]  C B Hall,et al.  Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. , 1998, The Journal of general virology.

[41]  J. Oxford,et al.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus. , 2010, American journal of respiratory and critical care medicine.

[42]  D. Fulton,et al.  Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children , 1994 .

[43]  A. Woodcock,et al.  Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. , 2006, American journal of respiratory and critical care medicine.

[44]  O. Ramilo,et al.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. , 1999, The Pediatric infectious disease journal.

[45]  W. Hall,et al.  CLINICAL SIGNIFICANCE OF PULMONARY FUNCTION TESTS Alterations in Pulmonary Function Following Respiratory Viral lnfection * , 2022 .

[46]  R. M. Hendry,et al.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. , 1985, The Journal of infectious diseases.

[47]  F. Pozo,et al.  Role of Rhinovirus in Hospitalized Infants With Respiratory Tract Infections in Spain , 2007, The Pediatric infectious disease journal.

[48]  D. Conti,et al.  Role of inducible nitric oxide synthase in asthma risk and lung function growth during adolescence , 2009, Thorax.

[49]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[50]  Yusuke Nakamura,et al.  A functional polymorphism in IL-18 is associated with severity of bronchial asthma. , 2009, American journal of respiratory and critical care medicine.

[51]  F. W. Denny,et al.  Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. , 1971, The Journal of pediatrics.

[52]  S. Hoffjan,et al.  RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life , 2002, European Respiratory Journal.

[53]  Paul E Moore,et al.  Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. , 2007, American journal of respiratory and critical care medicine.

[54]  M. Rathkopf,et al.  Causal Direction Between Respiratory Syncytial Virus Bronchiolitis and Asthma Studied in Monozygotic Twins , 2011, Pediatrics.

[55]  Martin J Firth,et al.  Association between antenatal cytokine production and the development of atopy and asthma at age 6 years , 2003, The Lancet.

[56]  K. Dietz,et al.  Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children , 2000, The Pediatric infectious disease journal.

[57]  Yao-Hsu Yang,et al.  Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[58]  R. Karron,et al.  Respiratory syncytial virus and metapneumovirus , 2007 .

[59]  A. Hamzaoui,et al.  Association between RANTES polymorphisms and asthma severity among Tunisian children. , 2007, Human immunology.

[60]  E. Simões,et al.  Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. , 2007, The Journal of pediatrics.

[61]  A. Milner,et al.  Respiratory status and allergy nine to 10 years after acute bronchiolitis , 1997, Archives of disease in childhood.

[62]  E. Walsh,et al.  Immunity to and frequency of reinfection with respiratory syncytial virus. , 1991, The Journal of infectious diseases.

[63]  Bjoern Peters,et al.  Is STAT6 Dependent During Respiratory Syncytial Virus Infection IL-13-Induced Airway Hyperreactivity , 2001 .

[64]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[65]  M. Griese.  Respiratory syncytial virus and pulmonary surfactant. , 2002, Viral immunology.

[66]  E. Norrby,et al.  Two distinct subtypes of human respiratory syncytial virus. , 1985, The Journal of general virology.

[67]  S. Wenzel,et al.  Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. , 2002, The American journal of medicine.

[68]  G. Larsen,et al.  Neural control mechanisms within airways: disruption by respiratory syncytial virus. , 1999, The Journal of pediatrics.

[69]  J. Tregoning,et al.  Childhood infections, the developing immune system, and the origins of asthma. , 2004, The Journal of allergy and clinical immunology.

[70]  L. Anderson,et al.  Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. , 2000, The Journal of infectious diseases.

[71]  P. Söderkvist,et al.  A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. , 2004, The Journal of allergy and clinical immunology.

[72]  H. Hammad,et al.  House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells , 2009, Nature Medicine.

[73]  T. Hudson,et al.  Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. , 2002, American journal of respiratory and critical care medicine.

[74]  K. Carlsen,et al.  VIRAL INFECTIONS OF THE RESPIRATORY TRACT IN HOSPITALIZED CHILDREN A Study from Oslo during a 90 Months’Period , 1983, Acta paediatrica Scandinavica.

[75]  S. Weiland,et al.  CX3CR1 Polymorphisms Are Associated with Atopy but Not Asthma in German Children , 2007, International Archives of Allergy and Immunology.

[76]  B. Kjellman,et al.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. , 2000, American journal of respiratory and critical care medicine.

[77]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[78]  E. Simões.  Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. , 2001, American journal of respiratory and critical care medicine.

[79]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.

[80]  T. Kimman,et al.  Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. , 2004, The Journal of infectious diseases.

[81]  U. Schauer,et al.  Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells , 2002, Clinical and experimental immunology.

[82]  W. Dupont,et al.  Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. , 2009, The Journal of allergy and clinical immunology.

[83]  W. Doyle,et al.  Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. , 2003, Human immunology.

[84]  P. Openshaw,et al.  Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood , 2002, The Journal of experimental medicine.

[85]  Mechanisms and limits of induced postnatal lung growth. , 2004, American journal of respiratory and critical care medicine.

[86]  L. Williams,et al.  Gene-environment interactions with CD14 C-260T and their relationship to total serum IgE levels in adults. , 2006, The Journal of allergy and clinical immunology.

[87]  H. Simpson,et al.  Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study. , 1982, British medical journal.

[88]  J. Towbin,et al.  Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[89]  P. Gustafsson,et al.  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life , 2010, Thorax.

[90]  F. Liu,et al.  Effect of variation in RANTES promoter on serum RANTES levels and risk of recurrent wheezing after RSV bronchiolitis in children from Han, Southern China , 2009, European Journal of Pediatrics.

[91]  B. Björkstén,et al.  Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. , 1995, Pediatrics.

[92]  P. Sly,et al.  TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1 , 2007, The Journal of Immunology.

[93]  L. Taussig,et al.  THE TUCSON CHILDREN'S RESPIRATORY STUDY. II. LOWER RESPIRATORY TRACT ILLNESS IN THE FIRST YEAR OF LIFE , 1989, American journal of epidemiology.

[94]  B. Graham,et al.  Pathogenesis of respiratory syncytial virus infection in the murine model. , 2005, Proceedings of the American Thoracic Society.

[95]  E. Gelfand,et al.  Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. , 2009, The Journal of allergy and clinical immunology.

[96]  Jeffrey D. Morton,et al.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease , 2008, Nature Medicine.

[97]  D. Duffy,et al.  Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. , 2009, American journal of respiratory and critical care medicine.

[98]  P. Cane,et al.  Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). , 1991, The Journal of general virology.

[99]  S. Holgate,et al.  Toll-like receptor 4 polymorphism and severity of atopy in asthmatics , 2004, Genes and Immunity.

[100]  V. Backer,et al.  The causal direction in the association between respiratory syncytial virus hospitalization and asthma. , 2009, The Journal of allergy and clinical immunology.

[101]  Ronald L Sorkness,et al.  Effects of viral respiratory infections on lung development and childhood asthma. , 2005, The Journal of allergy and clinical immunology.

[102]  R. Sorkness,et al.  Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats. , 1997, American journal of respiratory and critical care medicine.

[103]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[104]  C. Hogaboam,et al.  Respiratory Syncytial Virus Predisposes Mice to Augmented Allergic Airway Responses Via IL-13-Mediated Mechanisms1 , 2001, The Journal of Immunology.

[105]  T. Kimman,et al.  Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. , 2003, The Journal of infectious diseases.

[106]  P. Gulbrandsen,et al.  Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway , 2005, BMC pediatrics.

[107]  L. Anderson,et al.  Antigenic and genomic diversity within group A respiratory syncytial virus. , 1991, The Journal of infectious diseases.

[108]  T. Hudson,et al.  Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. , 2004, American journal of respiratory and critical care medicine.

[109]  A. Heinzmann,et al.  Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. , 2006, The Journal of infectious diseases.

[110]  P. Renzi,et al.  Reduced Interferon- γ Production in Infants with Bronchiolitis and Asthma , 1999 .

[111]  E. Hey,et al.  Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. , 1982, British medical journal.

[112]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[113]  D. Chaplin,et al.  Antigen-Nonspecific Recruitment of Th2 Cells to the Lung as a Mechanism for Viral Infection-Induced Allergic Asthma1 , 2002, The Journal of Immunology.

[114]  M. Rämet,et al.  Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. , 2002, The Journal of infectious diseases.

[115]  C. Dinarello.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. , 1999, The Journal of allergy and clinical immunology.

[116]  O. Ruuskanen,et al.  Respiratory Picornaviruses and Respiratory Syncytial Virus as Causative Agents of Acute Expiratory Wheezing in Children , 2004, Emerging infectious diseases.

[117]  M. Hibbert,et al.  Tracking of lung function in healthy children and adolescents , 1990, Pediatric pulmonology.

[118]  R. Lemanske.  Issues in understanding pediatric asthma: epidemiology and genetics. , 2002, The Journal of allergy and clinical immunology.

[119]  W. Dupont,et al.  Evidence of a causal role of winter virus infection during infancy in early childhood asthma. , 2008, American journal of respiratory and critical care medicine.

[120]  C. Hall,et al.  Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children , 1993 .

[121]  C. O’Callaghan,et al.  Respiratory status and allergy after bronchiolitis. , 1992, Archives of disease in childhood.

[122]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. , 1973, American journal of epidemiology.

[123]  K M McConnochie,et al.  Severity of respiratory syncytial virus infection is related to virus strain. , 1997, The Journal of infectious diseases.

[124]  Jelle J Goeman,et al.  Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. , 2007, The Journal of infectious diseases.

[125]  J. Virchow,et al.  Neurotrophins: A Link between Airway Inflammation and Airway Smooth Muscle Contractility in Asthma? , 1999, International Archives of Allergy and Immunology.

[126]  G. Piedimonte,et al.  Respiratory syncytial virus prevention and therapy: Past, present, and future , 2011, Pediatric pulmonology.

[127]  A. Heinzmann,et al.  Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma , 2007, BMC pulmonary medicine.

[128]  Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. , 1998, Pediatrics.

[129]  C. Bai,et al.  Role of airway epithelial cells in development of asthma and allergic rhinitis. , 2008, Respiratory medicine.

[130]  G. Redding,et al.  Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. , 2003, Pediatrics.

[131]  R. Sorkness,et al.  Neonatal viral bronchiolitis and pneumonia induces bronchiolar hypoplasia and alveolar dysplasia in rats. , 1988, Laboratory investigation; a journal of technical methods and pathology.